Nektar Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NKTR and other ETFs, options, and stocks.About NKTR
Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit.
NKTR Key Statistics
Stock Snapshot
As of today, Nektar Therapeutics(NKTR) shares are valued at $76.61. The company's market cap stands at 2.2B, with a P/E ratio of -7.31.
On 2026-04-07, Nektar Therapeutics(NKTR) stock moved within a range of $73.00 to $77.02. With shares now at $76.61, the stock is trading +4.9% above its intraday low and -0.5% below the session's peak.
Trading activity shows a volume of 273.28K, compared to an average daily volume of 915.11K.
Over the past 52 weeks, Nektar Therapeutics(NKTR) stock has traded between a high of $78.81 and a low of $6.48.
Over the past 52 weeks, Nektar Therapeutics(NKTR) stock has traded between a high of $78.81 and a low of $6.48.
NKTR News
Nektar Therapeutics (NKTR) told investors its REZOLVE-AA trial followed stated eligibility criteria and protocol standards. Executives repeatedly described the...
Advertisement Company overview and recent stock performance Nektar Therapeutics (NKTR) has drawn fresh attention after an extended run in its share price, wit...
Analyst ratings
90%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.